Startseite
Märkte
Charts & Ideen
Algo
Nachrichten
Store
Broker
Herunterladen
Wirtschaftskalender
Handelssignale
WebTerminal
Geben Sie
/
ein, um zu suchen: @user, $symbol
Suche
Einloggen
Eröffnen Sie ein Konto
Deutsch
English
Русский
中文
Español
Português
日本語
한국어
Français
Italiano
Türkçe
SILO
#3978
Silo Pharma, Inc. Common Stock
0.3
7
+5.71%
Sektor:
Basis:
Gewinnwährung:
Tagesspanne
Jahresspanne
Tagesänderung
+5.71%
Monatliche Änderung
-2.63%
6 month change
-42.19%
Jahresänderung
-72.59%
Vorheriger Schlusskurs
0.3
5
Open
0.3
7
Bid
Ask
Low
0.3
7
High
0.3
7
Volumen
3
Märkte
Aktien
Gesundheitswesen
SILO
Open full chart
Financials
Overview
Finanzbericht
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
TTM
Key stats
Total common shares outstanding
1.7 M
1.97 M
3.16 M
2.84 M
4.48 M
—
Valuation ratios
Enterprise value
—
—
-1.67 M
799.02 K
85.37 K
9.06 M
Price to earnings ratio
—
—
-1.8
-1.27
-0.75
-3.14
Price to sales ratio
—
—
81.8
64.93
45.43
185.68
Price to cash flow ratio
—
—
-2
-1.45
-0.85
-2.99
Price to book ratio
—
—
0.68
0.76
0.65
1.14
Enterprise value to EBITDA ratio
—
—
—
—
-0.02
—
Profitability ratios
Return on assets %
2.13
0.37
-0.34
-0.48
-0.59
-0.76
Return on equity %
2.37
0.43
-0.38
-0.6
-0.87
-1.07
Return on invested capital %
4 129.66
-5 369.36
-4 045.39
-4 981.19
-7 388.04
-5 936.51
Gross margin %
-330.38
1
77.29
91.9
91.9
260.94
Operating margin %
6 287.34
-41.21
-4 231.34
-5 347.41
-6 526.44
-29.44 K
EBITDA margin %
-4 912.8
—
—
—
-6 517.86
-29.38 K
Net margin %
7 422.52
58.62
-4 558.98
-5 132.57
-6 092.59
-28.16 K
Liquidity ratios
Quick ratio
9.83
21.17
—
—
—
—
Current ratio
10.07
21.23
26.52
9.9
4.29
23.8
Inventory turnover
1.86
0
—
—
—
—
Asset turnover
0.04
1.12
0.01
0.01
0.01
0.01
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
0
0
0.04
0.01
—
—
Long term debt to total equity ratio
0
0
0.04
0.01
—
—
Per share metrics
Operating cash flow per share
—
-1.19
-1.53
-1.05
-1.04
-0.92
EBIT per share
—
2
-1.58
-1.25
-1.28
-1.06
EBITDA per share
—
—
—
—
-1.28
-1.06
Total debt per share
—
—
—
—
—
—
Cash per share
—
5.13
4.98
2.49
1.92
4.76
Net current asset value per share
—
5.42
5.07
2.49
1.93
4.86
Tangible book value per share
—
4.72
4.53
2.01
1.3
3.4
Working capital per share
—
5.17
4.88
2.24
1.48
3.9
Book value per share
—
4.72
4.53
2.01
1.37
3.58
Nachrichten
Silo Pharma kündigt Aktienrückkaufprogramm über 1 Mio. US-Dollar an – Aktie schießt in die Höhe
Silo Pharma stock surges on $1M share buyback program
Silo Pharma genehmigt Aktienrückkaufprogramm über 1 Million US-Dollar
Silo Pharma authorizes $1 million stock buyback program
Japan erteilt Patent für PTSD-Therapeutikum von Silo Pharma
Japan grants patent for Silo Pharma’s PTSD treatment
Silo Pharma unterzeichnet Absichtserklärung für klinische Studien mit Nasenspray SPC-15
Silo Pharma signs LOI with Allucent for SPC-15 nasal spray clinical trials
Silo Pharma CEO Weisblum buys $735 in company stock
Silo Pharma selects Allucent to support PTSD treatment IND submission
Silo Pharma selects Alphaledger T12 fund for blockchain asset investments
Aktionäre von Silo Pharma stimmen Änderung des Aktienplans und Reverse-Split zu